Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
62.18 -0.45 (-0.72%) 19:38 ET [NYSE]
62.09 x 19 62.20 x 1115
Realtime by (Cboe BZX)
62.09 x 19 62.20 x 1115
Realtime 62.20 +0.12 (+0.19%) 19:14 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
60.58
Day High
62.08
Open 60.67
Previous Close 62.63 62.63
Volume 7,832,903 7,832,903
Avg Vol 10,285,445 10,285,445
Stochastic %K 49.04% 49.04%
Weighted Alpha -57.24 -57.24
5-Day Change +4.00 (+6.89%) +4.00 (+6.89%)
52-Week Range 57.00 - 148.15 57.00 - 148.15
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 281,054,144
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 42,108 M
  • Annual Income, $ 14,643 M
  • EBIT $ 18,609 M
  • EBITDA $ 21,380 M
  • 60-Month Beta 0.61
  • Price/Sales 6.53
  • Price/Cash Flow 15.79
  • Price/Book 13.22

Options Overview Details

View History
  • Implied Volatility 50.48% ( +1.65%)
  • Historical Volatility 50.67%
  • IV Percentile 86%
  • IV Rank 56.92%
  • IV High 70.99% on 04/08/25
  • IV Low 23.37% on 06/12/24
  • Put/Call Vol Ratio 1.38
  • Today's Volume 29,063
  • Volume Avg (30-Day) 40,688
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 514,982
  • Open Int (30-Day) 486,702

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.91
  • Number of Estimates 4
  • High Estimate 0.94
  • Low Estimate 0.88
  • Prior Year 0.83
  • Growth Rate Est. (year over year) +9.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.00 +8.91%
on 04/21/25
Period Open: 73.60
72.86 -14.80%
on 03/26/25
-11.52 (-15.65%)
since 03/25/25
3-Month
57.00 +8.91%
on 04/21/25
Period Open: 87.97
93.80 -33.82%
on 02/25/25
-25.89 (-29.43%)
since 01/24/25
52-Week
57.00 +8.91%
on 04/21/25
Period Open: 125.79
148.15 -58.10%
on 06/25/24
-63.71 (-50.65%)
since 04/25/24

Most Recent Stories

More News
Why Novo Nordisk Stock Dropped Today

Ignore the noise. Novo Nordisk stock is a bargain.

NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)
The Best Stock to Buy With Less Than $60 in the Market Sell-Off

Plenty of stocks with attractive businesses trade on the market for hundreds of dollars per share -- or more. However, it's possible to find excellent stocks that may become undervalued when either the...

NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)
Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs

Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over year to CHF 15.4 billion and were up 6% at constant exchange rates (CER).(Find...

NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)
REGN : 602.64 (+0.48%)
RHHBY : 39.5200 (-0.58%)
Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY

Take a deep dive into Eli Lilly's latest clinical GLP-1 results that sent shares soaring. The company has a big opportunity to serve needle-phobic patients.

NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)
PFE : 22.92 (+0.61%)
Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?

Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results -- though strong by comparison to most of its peers -- haven't been as good as...

NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)
Is Eli Lilly Stock a Buy?

The competitive landscape for GLP-1 agonist weight loss drugs has undergone a significant shake-up.

NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)
PFE : 22.92 (+0.61%)
Why Novo Nordisk Stock Popped Today

Novo Nordisk has a GLP-1 Ozempic pill. That's both good and bad news for Novo Nordisk stock.

NFLX : 1,101.53 (+0.42%)
NVO : 62.08 (-0.88%)
Think It's Too Late to Buy Novo Nordisk? Here's the Biggest Reason Why There's Still Time.

Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of GLP-1 obesity drugs. Front and center of this is Novo Nordisk (NYSE: NVO),...

NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)
Down 60%, Is This Growth Stock Too Cheap to Ignore?

In this video, I will cover recent updates regarding Novo Nordisk (NYSE: NVO) . Watch the short video to learn more, consider subscribing, and click the special offer link below.

NFLX : 1,101.53 (+0.42%)
NVDA : 111.01 (+4.30%)
NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)
Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?

Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019. Yet the stock has since plummeted 61% from its peak value.

NVO : 62.08 (-0.88%)
LLY : 884.54 (+2.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 64.41
2nd Resistance Point 63.34
1st Resistance Point 62.71
Last Price 62.08
1st Support Level 61.01
2nd Support Level 59.94
3rd Support Level 59.31

See More

52-Week High 148.15
Fibonacci 61.8% 113.33
Fibonacci 50% 102.57
Fibonacci 38.2% 91.82
Last Price 62.08
52-Week Low 57.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective